# GIST Oral Paclitaxel(Liporaxel)

> **NCT06326346** · PHASE2 · RECRUITING · sponsor: **Asan Medical Center** · enrollment: 28 (estimated)

## Conditions studied

- Gastrointestinal Stromal Tumors

## Interventions

- **DRUG:** Liporaxel

## Key facts

- **NCT ID:** NCT06326346
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06326346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06326346, "GIST Oral Paclitaxel(Liporaxel)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06326346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*